oral semaglutide cardiovascular protection FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection

Semaglutide Levers.Health

Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge eating disorder? And how can clinicians protect patients from risk?

Compounded semaglutide is not the same as FDA-approved. The FDA has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before

Novo Nordisk announced that US patients can now get a month's supply of Ozempic, the blockbuster diabetes drug, for $499, for those who pay for medications on their own and don't go

Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6 - Frontiers

The FDA has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and